• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.17%

    More On ARYX


    ARYx Therapeutics, Inc. (ARYX)

    -Other OTC
    0.00 Dec 23, 11:46AM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2009Dec 31, 2008Dec 31, 2007
    Total Revenue -   19,724   4,158  
    Cost of Revenue -  232  262  
    Gross Profit -   19,492   3,896  
    Operating Expenses
    Research Development21,040  40,145  24,994  
    Selling General and Administrative10,198  9,764  7,702  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (31,238) (30,417) (28,800)
    Income from Continuing Operations
    Total Other Income/Expenses Net78  1,127  2,591  
    Earnings Before Interest And Taxes(31,160)(29,290)(26,209)
    Interest Expense2,007  1,928  1,352  
    Income Before Tax(33,167)(31,218)(27,561)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(33,167)(31,218)(27,561)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (33,167) (31,218) (27,561)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (33,167) (31,218) (27,561)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.